Company Page
Transcripta Bio
Founders
Transcripta Bio is a Palo Alto-based platform biotech company that leverages AI, transcriptomics, and advanced robotic screening to discover small molecule drugs and novel biological mechanisms at unprecedented speed and scale. Its proprietary Drug-Gene Atlas, built from over 200 million experiments, maps the effects of thousands of compounds on 20,000 genes, while its Conductor AI suite predicts drug effects across the transcriptome to identify therapeutic candidates for diseases including neurological disorders, autism spectrum disorder, and FSHD. The company serves the pharmaceutical industry by providing a high-resolution, lower-risk pipeline for identifying and validating novel drug candidates across multiple disease areas simultaneously.
Company Founded in 2020
Healthtech & Biotech